
FDA AI approvals slowed amid reviews and shutdown
The Food and Drug Administration’s review slowdown and ongoing shutdown are delaying FDA AI approvals and stalling new submissions. Analysts now see longer timelines, more rejections, and rising uncertainty for makers of AI-enabled medical devices. What the slowdown means for FDA AI approvals Moreover, New data shows a measurable drop in FDA performance metrics. According […]






